Sentence examples for weak toxicity from inspiring English sources

Criterion of toxicity for fractions was established according to Déciga-campos et al. [ 23]: LC50 values > 1000 μg/mL (non-toxic), ≥ 500 ≤ 1000 μg/mL (weak toxicity) and < 500 μg/mL (toxic).

Indeed, amongst several quinones tested, chloranil was the only one to induce a weak toxicity in platelets [43] and was less toxic in PC12 cells than in primary hepatocytes [38].

Accumulation of toxic ATP analogues could account for the weak toxicity of clodronate reported in previous studies (Fromigue et al, 2000; Senaratne et al, 2000).

Interestingly, they had only a weak toxicity to normal hepatic cells (e.g. LO2 cells).

In our study, the GO sample with concentration of 100 μg/mL demonstrated weak toxicity.

As functionalized carbon nanotube is not immunogenic, it exhibits weak toxicity, similar to systems that have a spacious potential in various fields such as nanobiotechnology and nanomedicine.

Among the tested analogues, compounds 8 and 11 demonstrated potent inhibition of nitric oxide production with no or weak cell toxicity.

The Food and Drug Administration FDAA) has recognized ZnO as safe due to its lack of or very weak dark toxicity in vitro and in vivo (Hu et al. 2013).

Since the largest cytotoxic effect for the Dd-BLM conjugate is seen after the first 10 h of treatment, Fig. 5C), the weak Dd toxicity will not be important in Dd-BLM applications.

Our recommendations on experimental design are also presented, with a view to ending the current impasse on the reality, or otherwise, of low-dose or weak endocrine toxicities.

In the article "Natural Variability and the Influence of Concurrent Control Values on the Detection and Interpretation of Low-Dose or Weak Endocrine Toxicities," Ashby et al. (2004) discounted a number of studies reporting low-dose effects caused by endocrine-disrupting chemicals, including bisphenol A (BPA), based on variability in control values in experiments conducted at different times.